Stay updated on Nintedanib for Progressive Fibrosing ILD Clinical Trial

Sign up to get notified when there's something new on the Nintedanib for Progressive Fibrosing ILD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nintedanib for Progressive Fibrosing ILD Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    Added posted results for the INBUILD PF-ILD study, detailing primary and key secondary outcomes and time-to-event analyses.
    Difference
    0.2%
    Check dated 2025-11-03T00:57:17.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    1%
    Check dated 2025-10-05T08:55:13.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Page now shows Revision: v3.1.0 and removes several drug-related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) with an earlier revision v3.0.2 still referenced; indicates content reorganization and consolidation.
    Difference
    0.1%
    Check dated 2025-09-28T03:07:13.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed as a minor UI change.
    Difference
    0.1%
    Check dated 2025-09-13T17:37:55.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-06T15:04:49.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The webpage has been updated to include new facility names and locations, particularly in South Korea, Russia, and several European countries, while also removing some previous location entries. Additionally, there are new references to drug safety and studies related to nintedanib.
    Difference
    6%
    Check dated 2025-08-30T11:52:43.000Z thumbnail image

Stay in the know with updates to Nintedanib for Progressive Fibrosing ILD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nintedanib for Progressive Fibrosing ILD Clinical Trial page.